These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9541034)

  • 21. Hepatic and serologic toxicity of systemic interleukin-2 and/or interferon-alpha. Evidence of a risk-benefit advantage of subcutaneous therapy.
    Schomburg A; Kirchner H; Lopez-Hänninen E; Menzel T; Rudolph P; Körfer A; Fenner M; Poliwoda H; Atzpodien J
    Am J Clin Oncol; 1994 Jun; 17(3):199-209. PubMed ID: 7910716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cocaine and metabolite concentrations in plasma during repeated oral administration: development of a human laboratory model of chronic cocaine use.
    Jufer RA; Walsh SL; Cone EJ
    J Anal Toxicol; 1998 Oct; 22(6):435-44. PubMed ID: 9788518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delta-pH method for measuring blood cholinesterase. A study on the effect of temperature.
    Ellin RI; Vicario PP
    Arch Environ Health; 1975 May; 30(5):263-5. PubMed ID: 236736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correlation and conversion of plasma cholinesterase activity values using three techniques].
    Carmona-Fonseca J
    Rev Panam Salud Publica; 2007 Jul; 22(1):35-40. PubMed ID: 17931486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Donepezil treatment and the subjective effects of intravenous cocaine in dependent individuals.
    Grasing K; Mathur D; Newton TF; DeSouza C
    Drug Alcohol Depend; 2010 Feb; 107(1):69-75. PubMed ID: 19836169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of drug-induced low plasma cholinesterase activity on the pharmacokinetics and pharmacodynamics of mivacurium.
    Ostergaard D; Rasmussen SN; Viby-Mogensen J; Pedersen NA; Boysen R
    Anesthesiology; 2000 Jun; 92(6):1581-7. PubMed ID: 10839906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of Ginkgo biloba extracts on the pharmacokinetics and pharmacodynamics of donepezil.
    Yasui-Furukori N; Furukori H; Kaneda A; Kaneko S; Tateishi T
    J Clin Pharmacol; 2004 May; 44(5):538-42. PubMed ID: 15102875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological variance of cholinesterase and 5'-nucleotidase in serum of healthy persons.
    Moses GC; Tuckerman JF; Henderson AR
    Clin Chem; 1986 Jan; 32(1 Pt 1):175-7. PubMed ID: 3000643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma and erythrocyte cholinesterase values for the common long-nosed armadillo, Dasypus novemcinctus.
    Herbst LH; Webb AI; Clemmons RM; Dorsey-Lee MR; Storrs EE
    J Wildl Dis; 1989 Jul; 25(3):364-9. PubMed ID: 2761009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoreactive plasma cholinesterase (EC 3.1.1.8) substance concentration, compared with cholinesterase activity concentration and albumin: inter- and intra-individual variations in a healthy population group.
    Brock A
    J Clin Chem Clin Biochem; 1990 Nov; 28(11):851-6. PubMed ID: 2077098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of pergolide on intravenous cocaine self-administration in men and women.
    Haney M; Foltin RW; Fischman MW
    Psychopharmacology (Berl); 1998 May; 137(1):15-24. PubMed ID: 9631952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total cholinesterase in plasma: biological variations and reference limits.
    Lepage L; Schiele F; Gueguen R; Siest G
    Clin Chem; 1985 Apr; 31(4):546-50. PubMed ID: 3978785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of blood cholinesterase levels with toxicity of sarin in rats.
    Young JF; Gough BJ; Suber RL; Gaylor DW
    J Toxicol Environ Health A; 2001 Feb; 62(3):161-74. PubMed ID: 11212943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal intrapersonal physiological variability of cholinesterase activity in human plasma and erythrocytes.
    Sidell FR; Kaminskis A
    Clin Chem; 1975 Dec; 21(13):1961-3. PubMed ID: 1192590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between pharmacokinetics and pharmacodynamics of eptastigmine in young healthy volunteers.
    Imbimbo BP; Licini M; Schettino M; Mosca A; Onelli E; Zecca L; Giustina A
    J Clin Pharmacol; 1995 Mar; 35(3):285-90. PubMed ID: 7608318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma cholinesterase activity and tachyphylaxis during prolonged succinylcholine infusion.
    Delisle S; Lebrun M; Bevan DR
    Anesth Analg; 1982 Nov; 61(11):941-4. PubMed ID: 7137612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
    Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
    Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholinesterase status, pharmacokinetics and laboratory findings during obidoxime therapy in organophosphate poisoned patients.
    Thiermann H; Mast U; Klimmek R; Eyer P; Hibler A; Pfab R; Felgenhauer N; Zilker T
    Hum Exp Toxicol; 1997 Aug; 16(8):473-80. PubMed ID: 9292288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of an automated spectrophotometric assay for the determination of cholinesterase activity in canine serum.
    Furlanello T; Simonato G; Caldin M; De Lorenzi D; Lubas G; Bernardini D; Solano-Gallego L
    Vet Res Commun; 2006 Oct; 30(7):723-33. PubMed ID: 17004037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of plasma cholinesterase in rabbit and evaluation of the inhibitory potential of diazinon.
    Oropesa AL; Pérez-López M; Soler F
    Ecotoxicol Environ Saf; 2014 Feb; 100():39-43. PubMed ID: 24433789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.